SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for ABBOTT LABORATORIES (ABT) — Apr 13, 2015

ABBOTT LABORATORIES
Date: April 13, 2015 · CIK: 0000001800 · Accession: 0000000000-15-020865

AI Filing Summary & Sentiment

Date
April 13, 2015
Author
/s/ Sharon M. Blume
Form
UPLOAD
Company
ABBOTT LABORATORIES

Letter

April 13, 2015 Via E -mail Mr. Thomas C. Freyman Executive Vice President , Finance and Chief Financial Officer Abbott Laboratories 100 Abbott Park Road Abbott Park, Illinois 60064

Re: Abbott Laboratories Form 10-K for the Fiscal Year Ended December 31 , 2014 Filed February 27, 2015 File No. 1-02189

Dear Mr. Freyman :

We have completed our review of your filing. We remind you that our comments or changes to disclosu re in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the compa ny may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States . We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Sharon M. Blume

Show Raw Text
April 13, 2015

Via E -mail
Mr. Thomas C. Freyman
Executive  Vice President , Finance  and Chief Financial  Officer
Abbott Laboratories
100 Abbott Park Road
Abbott Park, Illinois 60064

Re: Abbott Laboratories
 Form 10-K for the Fiscal Year Ended December 31 , 2014
Filed February 27, 2015
 File No. 1-02189

Dear Mr. Freyman :

We have completed our review of your filing.  We remind you that our comments  or
changes to disclosu re in response to our comments  do not foreclose the Commission from taking
any action with respect to the company or the filing  and the compa ny may not assert staff
comments  as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States .  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

/s/ Sharon M. Blume

Sharon M. Blume
Accounting Branch Chief